LOTTE Biologics Completes Songdo Plant 1 Construction
INCHEON, South Korea and SAN DIEGO, June 21, 2026 LOTTE Biologics has announced the successful completion of major construction...
AI drug discovery AI healthcare artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
INCHEON, South Korea and SAN DIEGO, June 21, 2026 LOTTE Biologics has announced the successful completion of major construction...
SEOUL, South Korea, May 18, 2026 LOTTE Biologics announced an expanded antibody manufacturing collaboration with Ottimo Pharma to support...
